JPRN-jRCT2031210289招募中未知
Zedula Special Drug Use Observational Study Ovarian Cancer
Contact for Clinical Trial Information0 个研究点目标入组 300 人开始时间: 2021年8月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- •An individual who corresponds to any of the following:
- •- Ovarian cancer patients after initial chemotherapy (maintenance therapy)
- •- Patients with platinum antineoplastic drug sensitive recurrent ovarian cancer (maintenance therapy)
- •- Recurrent ovarian cancer with platinum-sensitive homologous recombination repair defects.
排除标准
- •Has a history of hypersensitivity to any of the ingredients of this drug.
研究者
相似试验
已完成
不适用
Special Drug Use-Results Survey for ZYTIGA Tablets 250 mg (Long-term Use)castration-resistant prostate cancerJPRN-UMIN000015894Janssen Pharmaceutical K.K.420
已完成
不适用
ORKEDIA Tablets Special Drug Use Results Survey -Survey on Long-Term Treatment in Patients with HemodialysisSecondary hyperparathyroidism (SHPT) on hemodialysisJPRN-UMIN000041834Kyowa Kirin Co., Ltd.2,542
已完成
2 期
Clinical trial of Annual SZ drug in Covid-19COVID-19.COVID-19, virus not identifiedU07.2IRCT20200607047682N1Shahid Beheshti University of Medical Sciences60
已完成
不适用
Drug utilization study in Pimpri Chinchwad (PCMC) area of PuneCTRI/2020/10/028303Amol Gujar
已完成
不适用
A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)Homozygous SitosterolemiaHypercholesterolemiaFamilial HypercholesterolemiaNCT00704444Organon and Co11,332